From August 18th 2026, GtoPdb will require users to register to use the website. Please see our blog post for more information.
|
Synonyms: GSK-484 | MMV-1793192 | MMV1793192
Compound class:
Synthetic organic
Comment: This GSK484 (MMV1793192) is an orally bioavailable compound with antimalarial activity [2]. The chemical structure was presented during the 2024 EFMC-ISMC and ACS (Rome) meeting's First Time Disclosures session. It is one of the structures claimed in patent WO2023094305A1 [1]. GSK484 is intended for the treatment of uncomplicated malaria with potential for resistance management. The compound was awarded MMV Project of the Year (2021).
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. |
|
|||||||||||||||||
| Guide to Malaria Pharmacology Comments |
| Exhibits fast-killing and favourable pharmacokinetics. Potential Target/Mechanism Of Action: As the precise mechanism of action of GSK484 is not yet known, we do not have a molecular target for this compound. |